Descripción

Supplementary data showing the effects of SIRT1 knockdown on melatonin's ability to regulate CES1 expression and lipid metabolism in prostate cancer cells.

Figure 29

Chart

Source Paper

Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.

Clinical and translational medicine (2021)

PMID: 34185414

DOI: 10.1002/ctm2.449

Cite This Figure

![Figure 29: Supplementary data showing the effects of SIRT1 knockdown on melatonin's ability to regulate CES1 expression and lipid metabolism in prostate cancer cells.]()

> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)

<figure>
  <img src="" alt="Supplementary data showing the effects of SIRT1 knockdown on melatonin's ability to regulate CES1 expression and lipid metabolism in prostate cancer cells." />
  <figcaption>Figure 29. Supplementary data showing the effects of SIRT1 knockdown on melatonin's ability to regulate CES1 expression and lipid metabolism in prostate cancer cells.<br>  Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption>
</figure>

Evidencia relacionada

Melatonin para Trastorno del Ritmo Circadiano

Calificación A · 176 estudios